Please login to read the full article.
Scrip Regulatory Affairs
Commission consults on GMP rules for active substances under EU falsified medicines legislation
23 January 2012
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Commission consults on plans to ensure EU-wide equivalence of imported active substances
- Draft EU regulation sets out uniform conditions for various pharmacovigilance activities
- EU-wide consensus on confidential commercial data in drug marketing applications
- EMA proposes to update qualified persons requirements on drug certification, batch release
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
